Activating the immune system at the site of a tumor can recruit and stimulate immune cells to destroy tumor cells.

Researchers have developed a synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immune activation.

Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound.

Researchers developed a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immune activation.

Researchers have developed a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immunity.

Scientists have created a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immune activation